SIMILAR PATTERNS OF AMINO ACIDS FOR 4B7Q_B_ZMRB601
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1h1c | HISTIDINOL-PHOSPHATEAMINOTRANSFERASE (Thermotogamaritima) |
PF00155(Aminotran_1_2) | 5 | ARG A 19GLU A 28SER A 107ARG A 308TYR A 23 | None | 1.44A | 4b7qB-1h1cA:undetectable | 4b7qB-1h1cA:19.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ij5 | PLASMODIAL SPECIFICLAV1-2 PROTEIN (Physarumpolycephalum) |
PF13202(EF-hand_5) | 5 | GLU A 120SER A 163GLU A 107GLU A 111ARG A 108 | None | 1.49A | 4b7qB-1ij5A:undetectable | 4b7qB-1ij5A:20.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ms8 | TRANS-SIALIDASE (Trypanosomacruzi) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 5 | ARG A 35ASP A 59GLU A 230ARG A 245TYR A 342 | DAN A 700 (-3.0A)DAN A 700 (-2.7A)DAN A 700 (-3.3A)DAN A 700 (-2.8A)DAN A 700 (-3.5A) | 0.74A | 4b7qB-1ms8A:20.3 | 4b7qB-1ms8A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mz5 | SIALIDASE (Trypanosomarangeli) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 36ASP A 60GLU A 231ARG A 246ARG A 315TYR A 343 | None | 0.73A | 4b7qB-1mz5A:20.7 | 4b7qB-1mz5A:20.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG N 118GLU N 119ASP N 151ARG N 224GLU N 227GLU N 276GLU N 277ARG N 292ASN N 294ARG N 371TYR N 406 | None | 0.82A | 4b7qB-1nmbN:63.0 | 4b7qB-1nmbN:45.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG N 118GLU N 119ASP N 151ASN N 347TYR N 406 | None | 1.23A | 4b7qB-1nmbN:63.0 | 4b7qB-1nmbN:45.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rzg | FAB 412D LIGHT CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 5 | ARG A 83GLU A 85ASP A 86GLU A 46ARG A 62 | NoneNoneNoneSUC A9002 (-2.9A)SUC A9002 (-4.2A) | 1.47A | 4b7qB-1rzgA:undetectable | 4b7qB-1rzgA:18.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 124GLU A 125ASP A 157ARG A 231GLU A 234GLU A 283GLU A 284ARG A 299ASN A 301ARG A 378TYR A 412 | None | 0.52A | 4b7qB-1v0zA:64.0 | 4b7qB-1v0zA:38.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 10 | ARG A 116GLU A 117ASP A 149ARG A 223GLU A 226GLU A 276ARG A 292ASN A 294ARG A 374TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-3.6A)IBA A 1 ( 4.5A)IBA A 1 (-3.9A)IBA A 1 (-3.9A)IBA A 1 (-3.5A)IBA A 1 ( 3.9A)IBA A 1 (-3.2A)None | 0.62A | 4b7qB-1vcjA:52.4 | 4b7qB-1vcjA:32.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 7 | ARG A 116GLU A 117ASP A 149ARG A 223GLU A 275ARG A 374TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-3.6A)IBA A 1 ( 4.5A)IBA A 1 (-4.1A)IBA A 1 (-3.2A)None | 1.32A | 4b7qB-1vcjA:52.4 | 4b7qB-1vcjA:32.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 5 | GLU A 226GLU A 276ARG A 292ASN A 294TYR A 409 | IBA A 1 (-3.9A)IBA A 1 (-3.9A)IBA A 1 (-3.5A)IBA A 1 ( 3.9A)None | 1.18A | 4b7qB-1vcjA:52.4 | 4b7qB-1vcjA:32.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w8o | BACTERIAL SIALIDASE (Micromonosporaviridifaciens) |
PF00754(F5_F8_type_C)PF10633(NPCBM_assoc)PF13088(BNR_2) | 5 | ARG A 68GLU A 260ARG A 276ARG A 342TYR A 370 | CIT A1649 ( 2.6A)GOL A1651 (-3.6A)CIT A1649 ( 2.7A)CIT A1649 ( 2.9A)CIT A1649 (-4.5A) | 0.52A | 4b7qB-1w8oA:22.1 | 4b7qB-1w8oA:19.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 119GLU A 120ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.70A | 4b7qB-1xogA:63.6 | 4b7qB-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.52A | 4b7qB-1xogA:63.6 | 4b7qB-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 1.03A | 4b7qB-1xogA:63.6 | 4b7qB-1xogA:41.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) |
PF13088(BNR_2) | 6 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.61A | 4b7qB-2bf6A:21.3 | 4b7qB-2bf6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f28 | SIALIDASE 2 (Homo sapiens) |
PF13088(BNR_2) | 5 | ARG A 21GLU A 218ARG A 237ARG A 304TYR A 334 | None | 0.47A | 4b7qB-2f28A:2.4 | 4b7qB-2f28A:22.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | None | 0.50A | 4b7qB-2htvA:69.6 | 4b7qB-2htvA:66.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | ARG A 118ASP A 151ARG A 224GLU A 227SER A 246GLU A 277ARG A 371TYR A 406 | None | 0.76A | 4b7qB-2htvA:69.6 | 4b7qB-2htvA:66.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | GLU A 119ARG A 224SER A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | None | 0.89A | 4b7qB-2htvA:69.6 | 4b7qB-2htvA:66.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qve | TYROSINE AMINOMUTASE (Streptomycesglobisporus) |
PF00221(Lyase_aromatic) | 5 | ARG A 328GLU A 229ARG A 321ASN A 266TYR A 325 | None | 1.25A | 4b7qB-2qveA:undetectable | 4b7qB-2qveA:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rhq | PHENYLALANYL-TRNASYNTHETASE BETACHAIN (Staphylococcushaemolyticus) |
PF01588(tRNA_bind)PF03147(FDX-ACB)PF03483(B3_4)PF03484(B5) | 5 | ARG B 383GLU B 266GLU B 6ARG B 244TYR B 262 | None | 1.37A | 4b7qB-2rhqB:undetectable | 4b7qB-2rhqB:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w20 | SIALIDASE A (Streptococcuspneumoniae) |
PF13088(BNR_2) | 6 | ARG A 347ASP A 372GLU A 647ARG A 663ARG A 721TYR A 752 | None | 0.71A | 4b7qB-2w20A:22.0 | 4b7qB-2w20A:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xzi | EXTRACELLULARSIALIDASE/NEURAMINIDASE, PUTATIVE (Aspergillusfumigatus) |
PF13088(BNR_2) | 6 | ARG A 59ASP A 84GLU A 249ARG A 265ARG A 322TYR A 358 | KDM A 500 (-2.7A)KDM A 500 (-2.8A)KDM A 500 (-3.6A)KDM A 500 (-2.7A)KDM A 500 ( 3.0A)KDM A 500 (-4.5A) | 0.55A | 4b7qB-2xziA:2.8 | 4b7qB-2xziA:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yw2 | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Aquifexaeolicus) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ARG A 378GLU A 100GLU A 71ARG A 287ASN A 285 | PO4 A 645 (-3.6A)NonePO4 A 645 (-2.9A)PO4 A 645 (-3.3A)None | 1.22A | 4b7qB-2yw2A:undetectable | 4b7qB-2yw2A:20.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.48A | 4b7qB-3ckzA:74.1 | 4b7qB-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.28A | 4b7qB-3ckzA:74.1 | 4b7qB-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 6 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.31A | 4b7qB-3ckzA:74.1 | 4b7qB-3ckzA:91.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ee4 | PROBABLERIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE (Mycobacteriumtuberculosis) |
PF00268(Ribonuc_red_sm) | 5 | ARG A 123GLU A 119ARG A 54SER A 50TYR A 124 | None | 1.47A | 4b7qB-3ee4A:undetectable | 4b7qB-3ee4A:18.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ek1 | ALDEHYDEDEHYDROGENASE (Brucellaabortus) |
PF00171(Aldedh) | 5 | GLU A 400SER A 423GLU A 399ARG A 424ASN A 421 | None | 1.47A | 4b7qB-3ek1A:undetectable | 4b7qB-3ek1A:21.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3esh | PROTEIN SIMILAR TOMETAL-DEPENDENTHYDROLASE (Staphylococcusaureus) |
PF00753(Lactamase_B) | 5 | GLU A 140ASP A 224SER A 182GLU A 137TYR A 152 | None | 1.48A | 4b7qB-3eshA:undetectable | 4b7qB-3eshA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fok | UNCHARACTERIZEDPROTEIN CGL0159 (Corynebacteriumglutamicum) |
no annotation | 5 | ARG A 115ASP A 127SER A 186GLU A 182ASN A 195 | None | 1.02A | 4b7qB-3fokA:undetectable | 4b7qB-3fokA:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fvc | GLYCOPROTEIN GP110 (Humangammaherpesvirus4) |
PF00606(Glycoprotein_B)PF17416(Glycoprot_B_PH1)PF17417(Glycoprot_B_PH2) | 5 | GLU A 289ARG A 291GLU A 242ASN A 240ARG A 273 | None | 1.23A | 4b7qB-3fvcA:undetectable | 4b7qB-3fvcA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lp8 | PHOSPHORIBOSYLAMINE-GLYCINE LIGASE (Ehrlichiachaffeensis) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ARG A 380GLU A 100GLU A 71ARG A 287ASN A 285 | UNX A 425 ( 4.0A)NoneNoneNoneNone | 1.33A | 4b7qB-3lp8A:undetectable | 4b7qB-3lp8A:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pqs | TRANSFERRIN-BINDINGPROTEIN (Actinobacilluspleuropneumoniae) |
PF01298(TbpB_B_D)PF17483(TbpB_C)PF17484(TbpB_A) | 5 | ARG A 221GLU A 170ASP A 244ARG A 164SER A 276 | GOL A3968 (-3.5A)GOL A3968 (-3.1A)GOL A 533 ( 4.2A)NoneNone | 1.45A | 4b7qB-3pqsA:undetectable | 4b7qB-3pqsA:23.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qfi | TRANSCRIPTIONALREGULATOR (Enterococcusfaecalis) |
PF03816(LytR_cpsA_psr) | 5 | ARG A 197ASP A 70ARG A 104ASN A 120ARG A 209 | None | 1.47A | 4b7qB-3qfiA:undetectable | 4b7qB-3qfiA:17.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qk7 | TRANSCRIPTIONALREGULATORS (Yersinia pestis) |
PF00532(Peripla_BP_1) | 5 | ARG A 144ASP A 223SER A 23ASN A 22TYR A 140 | None | 1.42A | 4b7qB-3qk7A:undetectable | 4b7qB-3qk7A:20.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sil | SIALIDASE (Salmonellaenterica) |
PF13859(BNR_3) | 6 | ARG A 37ASP A 62GLU A 231ARG A 246ARG A 309TYR A 342 | PO4 A 499 (-2.7A)GOL A 403 ( 3.4A)GOL A 402 (-3.3A)PO4 A 499 (-2.7A)PO4 A 499 (-3.0A)PO4 A 499 (-4.6A) | 0.83A | 4b7qB-3silA:20.1 | 4b7qB-3silA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3slt | SERINE PROTEASE ESPP (Escherichiacoli) |
PF03797(Autotransporter) | 5 | ARG A1033GLU A1168SER A1023GLU A1172TYR A1118 | None | 1.21A | 4b7qB-3sltA:undetectable | 4b7qB-3sltA:19.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | LNV A 901 (-3.0A)LNV A 901 (-3.6A)LNV A 901 (-3.4A)LNV A 901 (-4.1A)LNV A 901 (-3.4A)LNV A 901 (-2.9A)LNV A 901 ( 3.8A)LNV A 901 (-2.8A)LNV A 901 (-4.0A)LNV A 901 (-2.9A)LNV A 901 (-4.8A) | 0.26A | 4b7qB-3ti8A:69.9 | 4b7qB-3ti8A:48.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | LNV A 801 (-2.8A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-4.2A)LNV A 801 (-3.5A)LNV A 801 (-2.9A)LNV A 801 (-3.8A)LNV A 801 (-3.0A)LNV A 801 (-4.0A)LNV A 801 (-2.9A)LNV A 801 (-4.4A) | 0.28A | 4b7qB-3tiaA:63.8 | 4b7qB-3tiaA:45.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w3a | V-TYPE ATP SYNTHASEALPHA CHAIN (Thermusthermophilus) |
PF00006(ATP-synt_ab)PF02874(ATP-synt_ab_N)PF16886(ATP-synt_ab_Xtn) | 5 | GLU A 38SER A 338GLU A 343ARG A 357TYR A 25 | None | 1.45A | 4b7qB-3w3aA:undetectable | 4b7qB-3w3aA:19.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zie | SEPF-LIKE PROTEIN (Archaeoglobusfulgidus) |
PF04472(SepF) | 5 | ARG A 55GLU A 52GLU A 56ARG A 40TYR A 38 | None | 1.13A | 4b7qB-3zieA:undetectable | 4b7qB-3zieA:12.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.60A | 4b7qB-4b7jA:74.9 | 4b7qB-4b7jA:99.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bbw | SIALIDASE(NEURAMINIDASE) (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 5 | ARG A 204ASP A 229GLU A 399ARG A 415TYR A 510 | None | 0.88A | 4b7qB-4bbwA:21.5 | 4b7qB-4bbwA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cgs | POLYMERASE SUBUNITPA (Dhorithogotovirus) |
no annotation | 5 | ARG A 163GLU A 162GLU A 31GLU A 166ARG A 28 | None | 1.20A | 4b7qB-4cgsA:undetectable | 4b7qB-4cgsA:15.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 11 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.49A | 4b7qB-4cpnA:53.2 | 4b7qB-4cpnA:34.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fj6 | GLYCOSIDE HYDROLASEFAMILY 33, CANDIDATESIALIDASE (Parabacteroidesdistasonis) |
PF13859(BNR_3)PF14873(BNR_assoc_N) | 6 | ARG A 200ASP A 225GLU A 395ARG A 411ARG A 475TYR A 506 | PO4 A 607 ( 2.6A)PO4 A 607 ( 3.8A)PO4 A 607 ( 4.8A)PO4 A 607 (-2.7A)PO4 A 607 (-2.8A)PO4 A 607 (-4.6A) | 0.63A | 4b7qB-4fj6A:21.4 | 4b7qB-4fj6A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fzh | HEMAGGLUTININ-NEURAMINIDASE (Avianavulavirus 1) |
PF00423(HN) | 5 | ARG A 174GLU A 401ARG A 416ARG A 498TYR A 526 | None | 0.77A | 4b7qB-4fzhA:9.4 | 4b7qB-4fzhA:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371 | SLB A 512 (-2.7A)SLB A 512 (-3.5A)SLB A 512 (-3.5A)SLB A 512 (-4.2A)NoneSLB A 512 (-2.8A)SLB A 512 (-2.7A)SLB A 512 (-3.1A)SLB A 512 ( 4.2A)SLB A 512 (-2.9A) | 0.30A | 4b7qB-4h53A:63.9 | 4b7qB-4h53A:41.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.60A | 4b7qB-4hzzA:63.2 | 4b7qB-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.96A | 4b7qB-4hzzA:63.2 | 4b7qB-4hzzA:40.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jf7 | HEMAGGLUTININ-NEURAMINIDASE (Mammalianrubulavirus 5) |
no annotation | 6 | ARG D 163GLU D 390ARG D 405ASN D 407ARG D 495TYR D 523 | SO4 D 608 ( 4.1A)NoneSO4 D 608 (-2.6A)NoneSO4 D 608 (-3.3A)None | 0.85A | 4b7qB-4jf7D:15.4 | 4b7qB-4jf7D:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mel | UBIQUITINCARBOXYL-TERMINALHYDROLASE 11 (Homo sapiens) |
PF06337(DUSP)PF14836(Ubiquitin_3) | 5 | GLU A 71GLU A 50GLU A 43ARG A 49TYR A 67 | None | 1.23A | 4b7qB-4melA:undetectable | 4b7qB-4melA:16.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.60A | 4b7qB-4mjuA:67.6 | 4b7qB-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 118ASP A 151ARG A 224GLU A 227TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 (-4.6A) | 0.86A | 4b7qB-4mjuA:67.6 | 4b7qB-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.06A | 4b7qB-4mjuA:67.6 | 4b7qB-4mjuA:53.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6k | BNR/ASP-BOX REPEATPROTEIN (Bacteroidescaccae) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 6 | ARG A 220ASP A 245GLU A 415ARG A 431ARG A 495TYR A 526 | EDO A 604 (-4.0A)EDO A 604 ( 4.3A)NoneNoneNoneNone | 0.57A | 4b7qB-4q6kA:21.3 | 4b7qB-4q6kA:22.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 36GLU A 37ASP A 69ARG A 143GLU A 146GLU A 195GLU A 196ARG A 211ASN A 213ARG A 290TYR A 324 | None | 0.56A | 4b7qB-4qn3A:63.9 | 4b7qB-4qn3A:38.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4sli | INTRAMOLECULARTRANS-SIALIDASE (Macrobdelladecora) |
PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 293ASP A 318GLU A 595ARG A 611ARG A 673TYR A 713 | CNP A 760 (-3.0A)CNP A 760 (-2.6A)CNP A 760 ( 4.5A)CNP A 760 (-3.0A)CNP A 760 (-3.0A)CNP A 760 (-4.0A) | 0.69A | 4b7qB-4sliA:21.4 | 4b7qB-4sliA:23.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x6k | ANHYDROSIALIDASE ([Ruminococcus]gnavus) |
PF13088(BNR_2) | 6 | ARG A 257ASP A 282GLU A 559ARG A 575ARG A 637TYR A 677 | 3XR A 802 (-3.0A)3XR A 802 (-2.5A)3XR A 802 ( 4.7A)3XR A 802 (-2.6A)3XR A 802 (-3.0A)3XR A 802 (-4.2A) | 0.72A | 4b7qB-4x6kA:8.3 | 4b7qB-4x6kA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xhb | SIALIDASE B (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 245ASP A 270GLU A 541ARG A 557ARG A 619TYR A 653 | NHE A 702 (-2.7A)NHE A 702 (-3.2A)NoneNHE A 702 (-2.8A)NHE A 702 (-2.9A)NHE A 702 (-4.8A) | 0.71A | 4b7qB-4xhbA:9.7 | 4b7qB-4xhbA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.80A | 4b7qB-4yw5A:3.0 | 4b7qB-4yw5A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b2d | HN PROTEIN (Mumpsrubulavirus) |
PF00423(HN) | 5 | ARG A 180GLU A 407ARG A 422ARG A 512TYR A 540 | SLT A 606 (-2.6A)SLT A 606 (-3.8A)SLT A 606 (-3.0A)SLT A 606 (-2.8A)SLT A 606 (-4.7A) | 0.59A | 4b7qB-5b2dA:7.2 | 4b7qB-5b2dA:21.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cwq | DESIGNED HELICALREPEAT PROTEIN (syntheticconstruct) |
no annotation | 5 | GLU A 68GLU A 119GLU A 64ARG A 114ASN A 116 | None | 1.46A | 4b7qB-5cwqA:undetectable | 4b7qB-5cwqA:16.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5znn | SORTILIN (Mus musculus) |
no annotation | 5 | GLU A 175ASP A 117SER A 528GLU A 479ASN A 481 | None | 1.39A | 4b7qB-5znnA:5.4 | 4b7qB-5znnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.39A | 4b7qB-6br6A:64.1 | 4b7qB-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eks | SIALIDASE (Vibrio cholerae) |
no annotation | 6 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.51A | 4b7qB-6eksA:11.6 | 4b7qB-6eksA:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6es9 | ACYL-COADEHYDROGENASE (Paracoccusdenitrificans) |
no annotation | 5 | ARG A 73GLU A 477GLU A 70GLU A 487ARG A 548 | None | 1.35A | 4b7qB-6es9A:undetectable | 4b7qB-6es9A:10.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU N 134ARG N 152ARG N 156TRP N 178 | None | 0.37A | 4b7qB-1nmbN:63.0 | 4b7qB-1nmbN:45.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 140ARG A 158ARG A 162TRP A 185 | None | 0.19A | 4b7qB-1v0zA:64.0 | 4b7qB-1v0zA:38.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 4 | LEU A 132ARG A 150ARG A 154TRP A 177 | NoneIBA A 1 (-3.9A)IBA A 1 (-4.1A)None | 0.41A | 4b7qB-1vcjA:52.4 | 4b7qB-1vcjA:32.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 135ARG A 153ARG A 157TRP A 180 | NoneABW A1000 (-4.1A)ABW A1000 (-4.2A)None | 0.54A | 4b7qB-1xogA:63.6 | 4b7qB-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | None | 0.51A | 4b7qB-2htvA:69.6 | 4b7qB-2htvA:66.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.73A | 4b7qB-3ckzA:74.1 | 4b7qB-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneLNV A 901 (-4.0A)LNV A 901 (-4.0A)None | 0.16A | 4b7qB-3ti8A:69.9 | 4b7qB-3ti8A:48.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneLNV A 801 (-3.9A)LNV A 801 (-4.0A)None | 0.15A | 4b7qB-3tiaA:63.8 | 4b7qB-3tiaA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 134ARG A 152ARG A 156TRP A 179 | NoneG39 A1470 (-3.9A)NoneNone | 0.17A | 4b7qB-4b7jA:74.9 | 4b7qB-4b7jA:99.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 4 | LEU A 131ARG A 149ARG A 153TRP A 176 | NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.19A | 4b7qB-4cpnA:53.2 | 4b7qB-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneSLB A 512 (-3.8A)NoneNone | 0.14A | 4b7qB-4h53A:63.9 | 4b7qB-4h53A:41.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneG39 A 509 (-3.9A)NoneNone | 0.20A | 4b7qB-4hzzA:63.2 | 4b7qB-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | None27S A 501 (-4.2A)NoneNone | 0.67A | 4b7qB-4mjuA:67.6 | 4b7qB-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | LEU A 52ARG A 70ARG A 74TRP A 97 | None | 0.27A | 4b7qB-4qn3A:63.9 | 4b7qB-4qn3A:38.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneE3M A 511 (-3.8A)NoneNone | 0.15A | 4b7qB-6br6A:64.1 | 4b7qB-6br6A:11.31 |